These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 9188488)

  • 1. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peptide sequence of heparin/heparan sulfate (HP/HS)-interacting protein supports selective, high affinity binding of HP/HS and cell attachment.
    Liu S; Julian J; Carson DD
    J Biol Chem; 1998 Apr; 273(16):9718-26. PubMed ID: 9545307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin/heparan sulfate (HP/HS) interacting protein (HIP) supports cell attachment and selective, high affinity binding of HP/HS.
    Liu S; Hoke D; Julian J; Carson DD
    J Biol Chem; 1997 Oct; 272(41):25856-62. PubMed ID: 9325317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface expression of HIP, a novel heparin/heparan sulfate binding protein, of human uterine epithelial cells and cell lines.
    Rohde LH; Julian J; Babaknia A; Carson DD
    J Biol Chem; 1996 May; 271(20):11824-30. PubMed ID: 8662617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
    Benezra M; Vlodavsky I; Bar-Shavit R
    Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; Nicolson GL
    Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
    Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
    J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cDNA cloning and expression of HIP, a novel cell surface heparan sulfate/heparin-binding protein of human uterine epithelial cells and cell lines.
    Liu S; Smith SE; Julian J; Rohde LH; Karin NJ; Carson DD
    J Biol Chem; 1996 May; 271(20):11817-23. PubMed ID: 8662616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
    Bame KJ; Danda J; Hassall A; Tumova S
    J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
    Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
    J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.
    Bashkin P; Razin E; Eldor A; Vlodavsky I
    Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.
    Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular localization of heparanase in human neutrophils.
    Matzner Y; Vlodavsky I; Bar-Ner M; Ishai-Michaeli R; Tauber AI
    J Leukoc Biol; 1992 Jun; 51(6):519-24. PubMed ID: 1613389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix.
    Yahalom J; Fibach E; Bar-Tana R; Fuks Z; Vlodavsky I
    Leuk Res; 1988; 12(9):711-7. PubMed ID: 2973542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase activity in cultured endothelial cells.
    Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
    J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.